CLOV catalysts
Catalysts and events linked to CLOV, newest first.
CLOV stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Clover Health PPO Plans Secure 5-Star CMS Quality Rating for 2027 2026-10-09 · Up | regulatory quality bonus payment revenue expansion and open enrollment access | CMS awarded 5-Star PPO and 4.5-Star HMO ratings to Clover Health for 2027. | Not recorded |
| Clover Health Medicare Advantage PPO Awarded CMS 5-Star Rating 2026-10-09 · Up | CMS quality bonus payment realization and continuous enrollment eligibility | CMS awarded PPO plans 5-Star rating and HMO plans 4.5-Star rating for 2027. | Not recorded |
| Clover Health Secures 5-Star CMS Rating for 2027 as MA Membership Expands 48% 2026-10-09 · Up | higher CMS quality bonus payment benchmark rates expanding premium revenue | CMS awarded Clover Health PPO plans a 5-Star rating and HMO plans a 4.5-Star rating for 2027. | Not recorded |
Do these developments change your position?
Review CLOV alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-10-09Clover Health PPO Plans Secure 5-Star CMS Quality Rating for 2027CLOV
- 2026-10-09Clover Health Secures 5-Star CMS Rating for 2027 as MA Membership Expands 48%CLOV
- 2026-10-09Clover Health Medicare Advantage PPO Awarded CMS 5-Star RatingCLOV
- 2026-10-09Clover Health Medicare Advantage PPO Awarded CMS 5-Star RatingCLOV
- 2026-10-09Clover Health Secures 5-Star CMS Rating for 2027 as MA Membership Expands 48%CLOV
- 2026-10-09Clover Health PPO Plans Secure 5-Star CMS Quality Rating for 2027CLOV
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.